| Tag | Content |
|---|
EnhancerAtlas ID | HS094-02618 |
Organism | Homo sapiens |
Tissue/cell | hMADS-3 |
Coordinate | chr1:161581420-161583260 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | TGTGCTTGAC GCACAGAAAG GGCTCAACAC ATTGTTGTTG AATAAAAGAA TGGATAAATT 60
GACACTGGGA AGTTGGAGTC CAAAGTTAAA CTTAGTCTCA ACTGCTCCCT GTTTTCATAG 120
ACCAGACTCC AGCCTACAAT ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA 180
CAAATAATTT TCGTAAATGT AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG 240
TCTTTCTCTA AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG 300
ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA 360
TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT 420
AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC 480
TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA 540
TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT 600
CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT 660
CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG 720
AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG 780
GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC 840
AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG 900
GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT 960
CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG 1020
AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC 1080
CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT 1140
TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG 1200
GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC 1260
TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA 1320
GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA 1380
GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT 1440
GTCTTCACTT GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA 1500
TTCCCGGCCG AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA 1560
AGGTCCCAGG CCAACCTAAA TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC 1620
CTTCCCGTTT CCAGTCCATA AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT 1680
CGGGCCCCCT CTCTGCTGGC AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA 1740
CTGAGTTACA TGGGAGAGAA GCAGGGATTC AGTTTGGCTG GGAATCAAAC TCTTTTGATA 1800
ATTTCCTAAT AAACTGATAG TCATTAGATG ACTTGTAGTC 1840
|
